Maze Therapeutics (MAZE) Institutional Ownership $13.40 -0.15 (-1.11%) As of 06/13/2025 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Maze Therapeutics (NASDAQ:MAZE)Number ofInstitutional Buyers(last 12 months)26TotalInstitutional Inflows(last 12 months)$273.95MNumber ofInstitutional Sellers(last 12 months)0 Get MAZE Insider Trade Alerts Want to know when executives and insiders are buying or selling Maze Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data MAZE Institutional Buying and Selling by Quarter Maze Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/29/2025 Rhumbline Advisers7,235$80K0.0%N/A0.017% 5/16/2025 Woodline Partners LP929,102$10.23M0.1%N/A2.121% 5/16/2025 Octagon Capital Advisors LP468,000$5.15M0.6%N/A1.069% 5/16/2025 Goldman Sachs Group Inc.13,129$145K0.0%N/A0.030% 5/16/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.5,135$57K0.0%N/A0.012% 5/16/2025 ARCH Venture Management LLC4,120,053$45.36M22.0%N/A9.407% 5/16/2025 Alyeska Investment Group L.P.125,000$1.38M0.0%N/A0.285% 5/15/2025 Frazier Life Sciences Management L.P.4,129,001$45.46M2.1%N/A9.428% 5/15/2025 Hhlr Advisors LTD.457,535$5.04M0.1%N/A1.045% 5/15/2025 Ghisallo Capital Management LLC30,000$330K0.0%N/A0.068% Get the Latest News and Ratings for MAZE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Maze Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/15/2025 Driehaus Capital Management LLC132,115$1.46M0.0%N/A0.302% 5/14/2025 Affinity Asset Advisors LLC250,000$2.75M0.3%N/A0.571% 5/14/2025 Corebridge Financial Inc.4,328$48K0.0%N/A0.010% 5/14/2025 Matrix Capital Management Company LP2,486,184$27.37M7.9%N/A5.677% 5/12/2025 Nuveen LLC11,375$125K0.0%N/A0.026% 5/12/2025 Invesco Ltd.20,552$226K0.0%N/A0.047% 5/9/2025 Deutsche Bank AG8,885$98K0.0%N/A0.020% 5/9/2025 TRV GP V LLC950,800$10.47M8.4%N/A2.171% 5/9/2025 TRV GP IV LLC6,073,958$66.87M72.0%N/A13.869% 5/9/2025 Charles Schwab Investment Management Inc.72,305$796K0.0%N/A0.165% 5/9/2025 Harvard Management Co. Inc.637,528$7.02M0.6%N/A1.456% 5/2/2025 Alphabet Inc.2,412,471$26.56M1.7%N/A5.508% 5/1/2025 New York State Common Retirement Fund2,300$25K0.0%N/A0.005% 4/29/2025 Bank of New York Mellon Corp17,233$190K0.0%N/A0.039% 4/23/2025 Bessemer Group Inc.481,790$5.31M0.0%N/A1.100% 4/16/2025 General Catalyst Group Management LLC1,035,910$11.41M1.3%N/A2.365% (Data available from 1/1/2016 forward) MAZE Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of MAZE shares? During the previous two years, 26 institutional investors and hedge funds held shares of Maze Therapeutics. The most heavily invested institutionals were TRV GP IV LLC ($66.87M), Frazier Life Sciences Management L.P. ($45.46M), ARCH Venture Management LLC ($45.36M), Matrix Capital Management Company LP ($27.37M), Alphabet Inc. ($26.56M), General Catalyst Group Management LLC ($11.41M), and TRV GP V LLC ($10.47M).Learn more on MAZE's institutional investors. Which institutional investors have been buying Maze Therapeutics stock? Of the 26 institutional investors that purchased Maze Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: TRV GP IV LLC ($6.07M), Frazier Life Sciences Management L.P. ($4.13M), ARCH Venture Management LLC ($4.12M), Matrix Capital Management Company LP ($2.49M), Alphabet Inc. ($2.41M), General Catalyst Group Management LLC ($1.04M), and TRV GP V LLC ($950.80K). How much institutional buying is happening at Maze Therapeutics? Institutional investors have bought a total of 24,881,924 shares in the last 24 months. This purchase volume represents approximately $273.95M in transactions. Related Companies NewAmsterdam Pharma Institutional Ownership Amneal Pharmaceuticals Institutional Ownership Recursion Pharmaceuticals Institutional Ownership Kiniksa Pharmaceuticals Institutional Ownership Vericel Institutional Ownership Denali Therapeutics Institutional Ownership CG Oncology Institutional Ownership Harmony Biosciences Institutional Ownership Agios Pharmaceuticals Institutional Ownership Indivior Institutional Ownership This page (NASDAQ:MAZE) was last updated on 6/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredBanks aren’t ready for this altcoin—are you?Donald Trump just fast-tracked TWO major crypto bills with an August deadline! Your window of opportunity i...Crypto 101 Media | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Maze Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Maze Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MAZE Stock Free MAZE Stock Alerts